Business Context and Reporting Period
This Form 8-K Current Report was filed by American Express Company on December 23, 2008. The report discloses a significant corporate event regarding the company's participation in a federal government financial assistance program.
Key Financial Metrics and Transaction Details
The filing details a capital transaction rather than standard operating financial results. Key metrics include:
- Capital Injection: Approximately $3.39 billion in aggregate purchase price.
- Instrument Type: Issuance of preferred stock and warrants to purchase common stock.
- Dividend Terms: 5% per annum for the first five years, increasing to 9% per annum thereafter.
- Counterparty: United States Department of the Treasury.
The filing text does not provide current period revenue, profit, cash flow, or debt levels.
Material Changes
The primary material change is the receipt of preliminary approval to participate in the Treasury's Troubled Asset Relief Program (TARP) Capital Purchase Program. This represents a significant shift in the company's capital structure and liquidity position, subject to standard closing conditions.
Outlook, Risks, and Contingencies
Management notes that the transaction is subject to standard closing conditions set forth in the Program investment documentation. The filing includes a forward-looking statement cautioning that actual results may differ due to the company's ability to complete the issuance of preferred shares and warrants. Additional risks include the company's performance and events subsequent to the third quarter of 2008.
Investor Verification Checklist
- Confirm the final closing of the $3.39 billion transaction with the U.S. Treasury.
- Review the specific terms of the preferred stock and warrants in the final investment documentation.
- Assess the impact of the 5% to 9% dividend obligation on future earnings per share.
- Monitor the company's liquidity position and credit ratings following the capital injection.